BioNTech SE - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BNTX Nasdaq 2836 www.biontech.de

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioNTech SE

Why Is BioNTech Stock Gaining Monday? - Sep 14th, 2026 8:35 am
BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients - Sep 14th, 2026 2:00 am
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat - Sep 11th, 2026 9:56 am
Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit? - Sep 9th, 2026 6:11 am
MRNA Stock Soars 143% in a Month: Time to Buy, Hold or Sell? - Sep 8th, 2026 8:40 am
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts - Sep 8th, 2026 5:28 am
BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy? - Sep 7th, 2026 6:33 pm
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III - Sep 1st, 2026 12:00 pm
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story? - Sep 1st, 2026 11:12 am
BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down - Aug 31st, 2026 10:32 am
BioNTech (BNTX) Ended A Phase 2 Colorectal Cancer Trial - Aug 28th, 2026 7:07 pm
BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna’s Big Win - Aug 28th, 2026 12:44 pm
BioNTech Kills a Cancer Trial Roche Helped Build - Aug 28th, 2026 12:02 pm
BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall - Aug 28th, 2026 11:47 am
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat - Aug 28th, 2026 8:58 am
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast - Aug 28th, 2026 8:09 am
BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline? - Aug 27th, 2026 3:52 pm
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine - Aug 27th, 2026 2:30 pm
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips - Aug 26th, 2026 9:25 am